A Study of CDX-1140, a CD40 Agonist, in Combination With Capecitabine and Oxaliplatin (CAPOX) and Keytruda in Subjects With Biliary Tract Carcinoma (BTC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
AstraZeneca
University of Nebraska
Canadian Cancer Trials Group
University of Edinburgh
University of Washington
National Institutes of Health Clinical Center (CC)
ASLAN Pharmaceuticals
ASLAN Pharmaceuticals
University of Wisconsin, Madison
Montefiore Medical Center
Wake Forest University Health Sciences
SWOG Cancer Research Network
SWOG Cancer Research Network
National Cancer Institute (NCI)
Stanford University
National Cancer Institute (NCI)
Swiss Cancer Institute
National Institutes of Health Clinical Center (CC)
Roswell Park Cancer Institute
NYU Langone Health